1558.HK Stock Analysis
15
Uncovered
YiChang HEC ChangJiang Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Market cap $B
0.941
Dividend yield
8.24 %
Shares outstanding
879.97 B
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases and others. The company is headquartered in Yichang, Hubei and currently employs 3,919 full-time employees. The company went IPO on 2015-12-29. The firm is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and metabolic drugs and cardiovascular drugs. Its main products include Kewei, Ertongshu, Oumeining, Xinhaining and Xining.